Aderemi Soyombo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Dabigatran is a direct thrombin inhibitor, approved in the United States for stroke prevention in nonvalvular atrial fibrillation and prevention and treatment of thromboembolism. It has been also used in patients with documented left atrial thrombus, where treatment with dabigatran effectively led to thrombus resolution. We present a rare case of left(More)
  • 1